These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32896109)

  • 1. Postponement of cardiovascular outcomes by statin use: A systematic review and meta-analysis of randomized clinical trials.
    Hansen MR; Hróbjartsson A; Pottegård A; Damkier P; Madsen KG; Pareek M; Olesen M; Hallas J
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):286-296. PubMed ID: 32896109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.
    Zhang X; Xiang C; Zhou YH; Jiang A; Qin YY; He J
    BMC Cardiovasc Disord; 2014 Feb; 14():19. PubMed ID: 24529196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S; Chen X; Chowdhury MM; Coughlin PA
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Hansen MR; Hróbjartsson A; Pottegård A; Damkier P; Larsen KS; Madsen KG; dePont Christensen R; Kristensen MEL; Christensen PM; Hallas J
    J Gen Intern Med; 2019 Aug; 34(8):1607-1614. PubMed ID: 31073857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
    Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
    Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.
    de Vries FM; Denig P; Pouwels KB; Postma MJ; Hak E
    Drugs; 2012 Dec; 72(18):2365-73. PubMed ID: 23186103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
    Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R
    Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
    Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S
    Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
    Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
    BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Verma S; Leiter LA; Mazer CD; Bain SC; Buse J; Marso S; Nauck M; Zinman B; Bosch-Traberg H; Rasmussen S; Michelsen MM; Bhatt DL
    Circulation; 2018 Oct; 138(15):1605-1607. PubMed ID: 30354517
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
    Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
    Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis.
    Riaz H; Khan SU; Rahman H; Shah NP; Kaluski E; Lincoff AM; Nissen SE
    Eur J Prev Cardiol; 2019 Mar; 26(5):533-543. PubMed ID: 30861690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of statins on average survival in randomised trials, an analysis of end point postponement.
    Kristensen ML; Christensen PM; Hallas J
    BMJ Open; 2015 Sep; 5(9):e007118. PubMed ID: 26408281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.